BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2004
View Archived Issues
Transgene highlights first quarter developments
Read More
Broad antitumor activity reported for Veglin in vivo
Read More
Orally active small molecule erythropoietic agent for the treatment of anemia
Read More
Panitumumab demonstrates encouraging antitumor activity
Read More
Bevacizumab demonstrates substantial clinical activity
Read More
Green tea extract may reverse tetracycline resistance
Read More
Metabolic conversion of anticancer agent SD-2007 to apicidin in rats
Read More
Topical tacrolimus found to improve skin lesions in patients with connective tissue disease
Read More
Remicade approved in E.U. for early rheumatoid arthritis
Read More
North American phase III trial initiated for Alzhemed
Read More
New European approval for Herceptin
Read More
Good safety profile reported for AP-23573 in patients with refractory tumors
Read More
Exanta launched in Germany
Read More
FDA lifts clinical hold on phase I NHL study of PPI-2458
Read More
GPI-0100 to be studied by Memorial Sloan-Kettering under new agreement
Read More
New trials to expand StaphVAX potential beyond ERSD patients
Read More
Liarozole receives U.S. orphan drug status for congenital ichthyosis
Read More
Immusol initiates collaboration with Affymetrix for oncology drug discovery
Read More
XenoPort presents new gemcitabine prodrugs
Read More
Novel HCV NS5B inhibitors jointly reported by ViroPharma and Wyeth
Read More
Roche claims two series of protein kinase inhibitors for use in cancer therapy
Read More
Three series of orexin antagonists patented by GSK researchers
Read More
New antibacterial agents covered by GSK patent
Read More
New antitumor agents developed by Sanofi-Synthelabo scientists
Read More
Mepolizumab reduces allergen-induced eosinophils and tenascin deposition
Read More
R-483 studied in animal models, diabetic patients
Read More
